High WWTR1 expression correlated with reduced progression-free survival specifically in HPV18+ patients, when compared with non-HPV18+ cervical cancer patients (those harbouring other HR-HPV types or HPV-) (Fig. 1G, H). This evidence concerns the gene WWTR1 and cervical carcinoma.